生物医药品CMO·CRO市场:供给来源，各类服务，各产品，各地区 - 市场规模，占有率，展望，机会分析，2023年～2030年

生物製药 CMO（合约製造组织）是一家为生物製药领域的其他公司提供从药品製造服务到包装等服务的公司。另一方面，CRO（合约药物开发组织）是一家透过外包研究工作来支持生物製药公司的公司。

市场动态：

全球生物製药 CMO 和这些是推动 CRO 市场成长的主要因素。

例如，2023 年 2 月，Lunaphore 和 Sirona Dx 宣布建立战略合作伙伴关係，使 Sirona Dx 成为美国第一家提供 Lunaphore 旗舰 COMET 空间生物学平台即服务的 CRO。COMET 补充了 Sirona Dx 的研究服务组合，并满足了各个领域的研究人员和生物製药团队的需求。COMET 在各个领域以及研究和药物开发的各个阶段提供广泛的研究应用。

本调查的主要特征

• 本报告提供以2022年为基准年的预测期间（2023-2030 年）之全球生物医药品CMO·CRO市场的市场规模和復合年增长率（CAGR %）相关的详区隔析。
• 并阐明不同部门市场的潜在收入机会，说明该市场具有魅力的投资主张矩阵。
• 同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
• 并基于企业亮点，各类型投资组合、主要焦点、财务业绩和市场策略等参数，介绍全球生物医药品CMO·CRO市场的主要参与者之企业简介。
• 藉由该报告提供的洞察，将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
• 全球生物医药品CMO·CRO市场报告配合该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
• 利益相关者可以透过全球生物医药品CMO·CRO市场用于分析的各种战略矩阵来帮助他们更容易做下决策。

目录

第1章 调查目的与前提条件

• 调查目的
• 前提条件
• 简称

第2章 市场概况

• 报告概要
  • 市场定义和范围
• 摘要整理
• Coherent Opportunity Map(COM)

第3章 市场动态，法规，趋势分析

• 市场动态
  • 全球外包趋势的提升
  • 严格的法律规范
  • 生物医药品产业的急速成长
• 影响分析
• 主要的焦点
• 法规情势
• 产品上市/核准
• PEST分析
• 波特分析
• 合併·收购情势

第4章 全球生物医药品CMO·CRO市场 - 冠状病毒(COVID-19)大流行病的影响

• COVID-19流行病学
• 供给面和需求面的分析
• 经济影响

第5章 生物医药品CMO·CRO的全球市场:供给来源，2023-2030年

• 哺乳类
• 非哺乳类

第6章 生物医药品CMO·CRO的全球市场:各类服务，2023-2030年

• 医药品受託製造
• 医药品开发业务受託

第7章 生物医药品CMO·CRO的全球市场:各产品，2023-2030年

• 生物医药品
• 生物相似药

第8章 生物医药品CMO·CRO的全球市场:各地区，2023-2030年

• 北美
• 南美
• 欧洲
• 亚太地区
• 中东
• 非洲

第9章 竞争情形

• Allphase Clinical Research
• AlcheraBio
• Alcami
• Akos Urgent Care
• Agilent
• AGC Biologics
• Affinity Life Sciences, Inc.
• Actimus Bio
• ACI Clinical
• Accumedix, Inc.
• Absorption Systems
• A10 Clinical Solutions
• Albuquerque Clinical Trials(ACT)
• Ajinomoto Bio-Pharma Services
• Advanced Clinical Services LLC
• ACM Global Laboratories
• Accelerated Enrollment Solutions
• AbbVie Contract Manufacturing
• Advanced BioScience Laboratories
• Advanced Clinical Research Institute
• Alliance for Clinical Trials in Oncology

第10章 章节

• 调查手法
• 关于出版社

Biopharmaceutical CMO (Contract Manufacturing Organization) is a company that serves other companies in the biopharmaceutical sector on a contract basis to offer services ranging from drug manufacturing services to packaging. While, Contract Research Organization (CRO) is a company that provides support to biopharmaceutical companies in the form of research services outsourced on a contract basis.

Market Dynamics:

Rise in burden of chronic diseases, increasing drug discovery and development, increasing demand for biologics and biosimilars, growing trend of outsourcing, increasing investment in research and development and the rapid growth of the biopharmaceutical industry are major factors expected to augment the growth of the global biopharmaceutical CMO and CRO market.

For instance, in February 2023, Lunaphore and Sirona Dx announced a strategic collaboration in which Sirona Dx will become the first US-based Contract Research Organization (CRO) to offer Lunaphore's flagship COMET spatial biology platform as a service. A COMET will complement Sirona Dx's portfolio of research service offerings to meet the needs of researchers and biopharma teams across various disciplines. COMET has a wide range of research applications across multiple disciplines and all stages of research and drug development.

Key features of the study:

• This report provides in-depth analysis of the global biopharmaceutical CMO and CRO market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global biopharmaceutical CMO and CRO market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include AlcheraBio, Alcami, Akos Urgent Care, Agilent, AGC Biologics, Affinity Life Sciences, Inc., Actimus Bio, ACI Clinical, Accumedix, Inc., Allphase Clinical Research, Absorption Systems, A10 Clinical Solutions, Albuquerque Clinical Trials (ACT), Ajinomoto Bio-Pharma Services, Advanced Clinical Services LLC, ACM Global Laboratories, Accelerated Enrollment Solutions, AbbVie Contract Manufacturing, Advanced BioScience Laboratories, Advanced Clinical Research Institute, and Alliance for Clinical Trials in Oncology, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global biopharmaceutical CMO and CRO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biopharmaceutical CMO and CRO market.

Detailed Segmentation:

• Global Biopharmaceutical CMO and CRO Market, By Source:
  • Mammalian
  • Non-mammalian
• Global Biopharmaceutical CMO and CRO Market, By Service:
  • Contract Manufacturing
  • Contract Research
• Global Biopharmaceutical CMO and CRO Market, By Product:
  • Biologics
  • Biosimilars
• Global Biopharmaceutical CMO and CRO Market, By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profiles:
  • Allphase Clinical Research
  • AlcheraBio
  • Alcami
  • Akos Urgent Care
  • Agilent
  • AGC Biologics
  • Affinity Life Sciences, Inc.
  • Actimus Bio
  • ACI Clinical
  • Accumedix, Inc.
  • Absorption Systems
  • A10 Clinical Solutions
  • Albuquerque Clinical Trials (ACT)
  • Ajinomoto Bio-Pharma Services
  • Advanced Clinical Services LLC
  • ACM Global Laboratories
  • Accelerated Enrollment Solutions
  • AbbVie Contract Manufacturing
  • Advanced BioScience Laboratories
  • Advanced Clinical Research Institute
  • Alliance for Clinical Trials in Oncology

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Source
  • Market Snapshot, By Service
  • Market Snapshot, By Product
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Growing trend of outsourcing across the globe
  • Stringent regulatory framework
  • Rapid growth of the biopharmaceutical industry
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Biopharmaceutical CMO and CRO Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Biopharmaceutical CMO and CRO Market, By Source, 2023-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Mammalian
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Non-mammalian
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

6. Global Biopharmaceutical CMO and CRO Market, By Service, 2023-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Contract Manufacturing
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Contract Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

7. Global Biopharmaceutical CMO and CRO Market, By Product, 2023-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• Biologics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
• Biosimilars
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

8. Global Biopharmaceutical CMO and CRO Market, By Region, 2023-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2018 - 2030
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Source, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Service, 2023-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2023-2030,(US$ Bn)

9. Competitive Landscape

• Allphase Clinical Research
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AlcheraBio
• Alcami
• Akos Urgent Care
• Agilent
• AGC Biologics
• Affinity Life Sciences, Inc.
• Actimus Bio
• ACI Clinical
• Accumedix, Inc.
• Absorption Systems
• A10 Clinical Solutions
• Albuquerque Clinical Trials (ACT)
• Ajinomoto Bio-Pharma Services
• Advanced Clinical Services LLC
• ACM Global Laboratories
• Accelerated Enrollment Solutions
• AbbVie Contract Manufacturing
• Advanced BioScience Laboratories
• Advanced Clinical Research Institute
• Alliance for Clinical Trials in Oncology
• Analyst Views

10. Section

• Research Methodology
• About us